Insider Activity of STARR KEVIN P
Biography of STARR KEVIN P
No biography is available at this moment.
No biography is available at this moment.
| 2017-04-12 | Sale | CytomX Therapeutics, Inc. CTMX | 10 percent owner | 56,714 0.158% | $16.36 | $927,586 | +23.75% | |
| 2016-09-06 | Sale | Editas Medicine, Inc. EDIT | 10 percent owner | 11,780 0.0329% | $15.90 | $187,331 | +8.83% | |
| 2015-11-12 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 75,000 0.0894% | $100.14 | $7.51M | -31.72% | |
| 2015-11-11 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 75,000 0.0912% | $107.65 | $8.07M | -35.21% | |
| 2015-09-24 | Sale | Larimar Therapeutics, Inc. LRMR | director | 273,158 1.105% | $43.90 | $11.99M | -83.88% | |
| 2014-09-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 90,000 0.1172% | $77.11 | $6.94M | +34.73% | |
| 2014-09-24 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 90,000 0.1179% | $79.08 | $7.12M | +32.14% | |
| 2013-03-26 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 52,000 0.0879% | $23.41 | $1.22M | +135.11% | |
| 2013-03-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 53,262 0.0468% | $12.26 | $652,856 | +133.24% |